Patent details

300840 Product Name: Elotuzumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300840
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2068874
Status:
SPC granted but not yet in force
Application number:
300840
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1088
Marketing Authorization Type:
EEA
Marketing Authorization Date:
13/05/2016
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
25/10/2016
First Marketing Authorization date:
13/05/2016
Grant date:
03/01/2017
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/10/2016
SPC/SPC Extension Expiration Date:
12/05/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
26/10/2016
 
 

 

Name:
AbbVie Biotherapeutics Inc.
Address:
1500 Seaport Boulevard, REDWOOD CITY, CA 94063, United States of America (US)

From:
26/10/2016
 
 

 

Name:
Dana-Farber Cancer Institute, Inc.
Address:
450 Brookline Avenue, BOSTON, MA 02215-5450, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
26/10/2016
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
01/17
Publication date:
04/01/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
43/16
Publication date:
28/10/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Other

Note:

Annual Fee

Annual Fee(s) Due Date:
31/08/2027
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
03/01/2017 Outgoing Correspondence Decision grant 1 PDF /2/0/4/1/0/0800101402/docs/300840_4_outgoingcorrespondence20170104094406518.pdf
03/01/2017 SPC Documents Certificate SPC 1 PDF /2/0/4/1/0/0800101402/docs/300840_10_supplprotectioncertificate20170104094406608.pdf
21/12/2016 SPC Documents Accompanying letter SPC 1 PDF /2/0/4/1/0/0800101402/docs/300840_3_supplprotectioncertificate20210112125129371.pdf
17/11/2016 Outgoing Correspondence Letter to applicant 1 PDF /2/0/4/1/0/0800101402/docs/300840_5_outgoingcorrespondence20161118093851559.pdf
28/10/2016 Outgoing Correspondence Confirmation receipt request 1 PDF /2/0/4/1/0/0800101402/docs/300840_0_outgoingcorrespondence20210112124926157.pdf
25/10/2016 SPC Documents Annex SPC 3 PDF /2/0/4/1/0/0800101402/docs/300840_1_supplprotectioncertificate20161026043154541.pdf
25/10/2016 SPC Documents Summary of the characteristics of the product 19 PDF /2/0/4/1/0/0800101402/docs/300840_2_supplprotectioncertificate20161026043154825.pdf
25/10/2016 SPC Documents Annex SPC 2 PDF /2/0/4/1/0/0800101402/docs/300840_6_supplprotectioncertificate20161026043154682.pdf
25/10/2016 SPC Documents Marketing Authorization SPC 3 PDF /2/0/4/1/0/0800101402/docs/300840_7_supplprotectioncertificate20161026043154756.pdf
25/10/2016 SPC Documents Annex SPC 1 PDF /2/0/4/1/0/0800101402/docs/300840_8_supplprotectioncertificate20161026043154612.pdf
25/10/2016 SPC Documents Accompanying letter SPC 3 PDF /2/0/4/1/0/0800101402/docs/300840_9_supplprotectioncertificate20210112124219099.pdf
25/10/2016 Application Form First filed application form 3 PDF /2/0/4/1/0/0800101402/docs/300840_11_applicationform20161026043154277.pdf
25/10/2016 SPC Documents Annex SPC 1 PDF /2/0/4/1/0/0800101402/docs/300840_12_supplprotectioncertificate20210112123957658.pdf